Tyler Friedrich, MD
Assistant Professor, Medicine-Medical Oncology
Medical School
- MD, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (2014)
Undergraduate School
- BA/BS, University of Colorado - Boulder (CO) (2009)
Residency
- University of Colorado, Internal Medicine (2016)
Fellowships
- University of Colorado, Medical Oncology (2022)
Department
Medicine-Medical OncologyPublications
- Leary JB, Hu J, Leal A, Davis SL, Kim S, Lentz R, Friedrich T, Herter W, Messersmith WA, Lieu CH. Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer. JCO Oncol Pract. 2024 Jul 24;:OP2400159. [Epub ahead of print] PubMed PMID: 39047212
- Lentz RW, Friedrich TJ, Blatchford PJ, Jordan KR, Pitts TM, Robinson HR, Davis SL, Kim SS, Leal AD, Lee MR, Waring MRN, Martin AC, Dominguez ATA, Bagby SM, Hartman SJ, Eckhardt SG, Messersmith WA, Lieu CH. A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer. Clin Cancer Res. 2024 Sep 3;30(17):3768-3778. PubMed PMID: 38869830
Practice Locations
CU Medicine Medical Oncology - Highlands Ranch Specialty Care Center1500 Park Central Drive
Suite 101
Highlands Ranch, CO 80129
720-516-1100
Hospital Affiliation
- UCHealth Highlands Ranch Hospital
Specialty Information
Specialties- Medical Oncology, Board Certification
- Hematology, Board Certification